Vinorelbine

Form: Intravenous Injection, Oral Capsule

Strength: Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg

Reference Brands: Navelbine® , Alocrest (US & EU)

Category: Oncology Cancer Care

Vinorelbine, marketed as Navelbine®, is an essential chemotherapy agent used for the treatment of non-small cell lung cancer (NSCLC) and advanced breast cancer. Available as an intravenous injection and oral capsules, with strengths like 10 mg/mL (IV) and 20 mg, 30 mg, and 40 mg (oral), Vinorelbine inhibits cell division by disrupting microtubule formation. Widely sourced by B2B pharmaceutical suppliers, Vinorelbine is available globally, including in the US and EU. Manufactured under GMP standards, it provides reliable therapy options for hospitals and oncology centers fighting aggressive cancers.